These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The high prevalence of alexithymia in hemodialyzed patients with secondary hyperparathyroidism unsuppressed by medical therapy is cured by parathyroidectomy. De Santo RM, Livrea A, De Santo NG, Conzo G, Bilancio G, Celsi S, Cirillo M. J Ren Nutr; 2010 Sep; 20(5 Suppl):S64-70. PubMed ID: 20797574 [Abstract] [Full Text] [Related]
24. An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group. Tokuyama K, Iseki K, Yoshi S, Yoshihara K, Nishime K, Uehara H, Tozawa M, Wake T, Arakaki M, Fukiyama K. Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):309-13. PubMed ID: 8741393 [Abstract] [Full Text] [Related]
32. [Influence of the vitamin D receptor gene polymorphism and 25-hydroxyvitamin D on arterial pressure in health individuals]. Muray S, Parisi E, Cardús A, Craver L, Marco MP, Fernández E. Nefrologia; 2003 May; 23 Suppl 2():32-6. PubMed ID: 12778851 [Abstract] [Full Text] [Related]
33. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM. Am J Nephrol; 2008 May; 28(1):97-106. PubMed ID: 17914251 [Abstract] [Full Text] [Related]
34. Nail disorders in patients with chronic renal failure and undergoing haemodialysis treatment: a case-control study. Dyachenko P, Monselise A, Shustak A, Ziv M, Rozenman D. J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):340-4. PubMed ID: 17309455 [Abstract] [Full Text] [Related]
35. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Căprioară M. Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492 [Abstract] [Full Text] [Related]
39. Vitamin D deficiency and associated factors in hemodialysis patients. Jean G, Charra B, Chazot C. J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733 [Abstract] [Full Text] [Related]
40. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A. Ann Acad Med Stetin; 2003 Sep; 49():111-30. PubMed ID: 15552843 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]